{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:32:09Z","timestamp":1740123129454,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T00:00:00Z","timestamp":1672185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T00:00:00Z","timestamp":1672185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s11033-022-08215-1","type":"journal-article","created":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T21:03:04Z","timestamp":1672261384000},"page":"2335-2341","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Germline variants associated with breast cancer in Khakass women of North Asia"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0051-8814","authenticated-orcid":false,"given":"Polina","family":"Gervas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksey","family":"Molokov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksei","family":"Zarubin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evgenii","family":"Topolnitskiy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolay","family":"Shefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lubov","family":"Pisareva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evgeny","family":"Choynzonov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadezda","family":"Cherdyntseva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,28]]},"reference":[{"issue":"8","key":"8215_CR1","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.3390\/genes13081296","volume":"13","author":"D BenAyed-Guerfali","year":"2022","unstructured":"BenAyed-Guerfali D, Kifagi C, BenKridis-Rejeb W et al (2022) The identification by exome sequencing of candidate genes in BRCA-negative Tunisian patients at a high risk of hereditary breast\/ovarian cancer. Genes (Basel) 13(8):1296. https:\/\/doi.org\/10.3390\/genes13081296","journal-title":"Genes (Basel)"},{"issue":"5","key":"8215_CR2","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1002\/cncr.31856","volume":"125","author":"MK Frey","year":"2019","unstructured":"Frey MK, Kopparam RV, Ni Zhou Z et al (2019) Prevalence of nonfounder BRCA1\/2 mutations in Ashkenazi Jewish patients presenting for genetic testing at a hereditary breast and ovarian cancer center. Cancer 125(5):690\u2013697","journal-title":"Cancer"},{"key":"8215_CR3","unstructured":"Petrucelli N, Daly MB, Pal T. BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer. 1998 Sep 4 [Updated 2022 May 26]. In Adam MP, Mirzaa GM, Pagon RA, et al (eds) GeneReviews\u00ae [Internet]. University of Washington, Seattle; 1993\u20132022."},{"key":"8215_CR4","doi-asserted-by":"publisher","first-page":"932957","DOI":"10.3389\/fonc.2022.932957","volume":"12","author":"ACLVC Gifoni","year":"2022","unstructured":"Gifoni ACLVC, Gifoni MAC, Wotroba CM et al (2022) Hereditary Breast Cancer in the Brazilian State of Cear\u00e1 (The CHANCE Cohort): higher-than-expected prevalence of recurrent germline pathogenic variants. Front Oncol 12:932957. https:\/\/doi.org\/10.3389\/fonc.2022.932957","journal-title":"Front Oncol"},{"key":"8215_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41698-022-00276-6","volume":"6","author":"E Rempel","year":"2022","unstructured":"Rempel E, Kluck K, Beck S et al (2022) Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD). NPJ Precis Oncol 6:36. https:\/\/doi.org\/10.1038\/s41698-022-00276-6","journal-title":"NPJ Precis Oncol"},{"key":"8215_CR6","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1134\/S1022795420070078","volume":"56","author":"VN Kharkov","year":"2020","unstructured":"Kharkov VN, Novikova LM, Shtygasheva OV et al (2020) Gene pool of Khakass and Shors for Y chromosome markers: common components and tribal genetic structure. Russ J Genet 56:849\u2013855. https:\/\/doi.org\/10.1134\/S1022795420070078","journal-title":"Russ J Genet"},{"key":"8215_CR7","unstructured":"Kolga M (2001) The red book of the peoples of the Russian Empire (NGO Red Book)."},{"key":"8215_CR8","unstructured":"Dykhno YuA, Chernenko ON (2012) Analysis of risk factors for breast cancer in women of the republic of Khakassia. Siberian Oncol J 6(54). (in Russ.)"},{"issue":"3","key":"8215_CR9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.17116\/onkolog20165357-61","volume":"5","author":"LF Pisareva","year":"2016","unstructured":"Pisareva LF, Odintsova IN, Ananina OA, Chernenko ON, Dykhno YuA (2016) Breast cancer in the Republic of Khakassia. PA Herzen J Oncol 5(3):57\u201361","journal-title":"PA Herzen J Oncol"},{"key":"8215_CR10","unstructured":"Kaprin A (2019) Malignant neoplasms in Russia 2018. http:\/\/www.oncology.ru\/service\/statistics\/. Accessed 26 June 2018."},{"issue":"9","key":"8215_CR11","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.3390\/genes11091076","volume":"11","author":"V Jaravine","year":"2020","unstructured":"Jaravine V, Balmford J, Metzger P, Boerries M, Binder H, Boeker M (2020) Annotation of human exome gene variants with consensus pathogenicity. Genes (Basel) 11(9):1076. https:\/\/doi.org\/10.3390\/genes11091076","journal-title":"Genes (Basel)"},{"key":"8215_CR12","doi-asserted-by":"crossref","unstructured":"Kwong A, et al (2016) Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countries. J Med Genet.","DOI":"10.1136\/jmedgenet-2015-103132"},{"key":"8215_CR13","doi-asserted-by":"crossref","unstructured":"Nakamura S, et al (2016) Current status of the management of hereditary breast and ovarian cancer in Asia: first report by the Asian BRCA Consortium. Public Health Genomics.","DOI":"10.1159\/000441714"},{"issue":"1","key":"8215_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2478\/jomb-2018-0037","volume":"38","author":"N Alyahri","year":"2019","unstructured":"Alyahri N, Abdi S, Khan W et al (2019) Novel associations between BRCA1 variants C.181 T>G (Rs28897672) and ovarian CRISK in Saudi Females. J Med Biochem 38(1):13\u201321. https:\/\/doi.org\/10.2478\/jomb-2018-0037","journal-title":"J Med Biochem"},{"key":"8215_CR15","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1002\/humu.9454","volume":"10","author":"S Cavalieri","year":"2006","unstructured":"Cavalieri S, Funaro A, Porcedda P, Turinetto V, Migone N, Gatti RA, Brusco A (2006) ATM mutations in Italian families with ataxia telangiectasia include two distinct large genomic deletions. Hum Mutat 10:1061","journal-title":"Hum Mutat"},{"issue":"6","key":"8215_CR16","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.molcel.2009.09.007","volume":"35","author":"Z Cai","year":"2009","unstructured":"Cai Z, Chehab NH, Pavletich NP (2009) Structure and activation mechanism of the CHK2 DNA damage checkpoint kinase. Mol Cell 35(6):818\u2013829","journal-title":"Mol Cell"},{"issue":"7","key":"8215_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2005.038331","volume":"43","author":"O Kilpivaara","year":"2006","unstructured":"Kilpivaara O, Alhopuro P, Vahteristo P, Aaltonen LA, Nevanlinna H (2006) CHEK2 I157T associates with familial and sporadic colorectal cancer. J Med Genet 43(7):e34","journal-title":"J Med Genet"},{"issue":"6","key":"8215_CR18","doi-asserted-by":"publisher","first-page":"R119","DOI":"10.1186\/bcr3062","volume":"13","author":"A Desrichard","year":"2011","unstructured":"Desrichard A, Bidet Y, Uhrhammer N, Bignon YJ (2011) CHEK2 contribution to hereditary breast cancer in non-BRCA families. Breast Cancer Res 13(6):R119","journal-title":"Breast Cancer Res"},{"issue":"6","key":"8215_CR19","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1159\/000472231","volume":"4","author":"I Vorechovsk\u00fd","year":"1996","unstructured":"Vorechovsk\u00fd I, Luo L, Prudente S, Chessa L, Russo G, Kanariou M, James M, Negrini M, Webster AD, Hammarstr\u00f6m L (1996) Exon-scanning mutation analysis of the ATM gene in patients with ataxia-telangiectasia. Eur J Hum Genet 4(6):352\u2013355","journal-title":"Eur J Hum Genet"},{"key":"8215_CR20","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/j.1469-1809.2009.00535.x","volume":"73","author":"L Chessa","year":"2009","unstructured":"Chessa L, Piane M, Magliozzi M, Torrente I, Savio C, Lulli P, Luca AD, Dallapiccola B (2009) Founder effects for ATM gene mutations in Italian Ataxia Telangiectasia families. Ann Hum Genet 73:532\u2013539","journal-title":"Ann Hum Genet"},{"key":"8215_CR21","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1007\/s12017-013-8240-3","volume":"15","author":"Y Huang","year":"2013","unstructured":"Huang Y, Yang L, Wang J, Yang F, Xiao Y, Xia R, Yuan X, Yan M (2013) Twelve novel Atm mutations identified in Chinese ataxia telangiectasia patients. Neuromol Med 15:536\u2013540","journal-title":"Neuromolecular Med"},{"issue":"11","key":"8215_CR22","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/ejhg.2014.16","volume":"22","author":"L Cast\u00e9ra","year":"2014","unstructured":"Cast\u00e9ra L, Krieger S, Rousselin A, Legros A, Baumann JJ, Bruet O, Brault B, Fouillet R, Goardon N, Letac O, Baert-Desurmont S, Tinat J, Bera O, Dugast K, Berthet P, Polycarpe F, Layet V, Hardouin A, Fr\u00e9bourg T, Vaur D (2014) Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes. Eur J Hum Genet 22(11):1305\u20131313","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"8215_CR23","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/cge.12735","volume":"90","author":"PS Ng","year":"2016","unstructured":"Ng PS, Wen WX, Fadlullah MZ, Yoon SY, Lee SY, Thong MK, Yip CH, Mohd Taib NA, Teo SH (2016) Identification of germline alterations in breast cancer predisposition genes among Malaysian breast cancer patients using panel testing. Clin Genet 90(4):315\u2013323","journal-title":"Clin Genet"},{"issue":"2","key":"8215_CR24","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1349-7006.2007.00694.x","volume":"99","author":"H Tao","year":"2008","unstructured":"Tao H, Shinmura K, Suzuki M, Kono S, Mibu R, Tanaka M, Kakeji Y, Maehara Y, Okamura T, Ikejiri K, Futami K, Yasunami Y, Maekawa T, Takenaka K, Ichimiya H, Imaizumi N, Sugimura H (2008) Association between genetic polymorphisms of the base excision repair gene MUTYH and increased colorectal cancer risk in a Japanese population. Cancer Sci 99(2):355\u2013360","journal-title":"Cancer Sci"},{"key":"8215_CR25","doi-asserted-by":"publisher","first-page":"10424","DOI":"10.1038\/srep10424","volume":"5","author":"K Klonowska","year":"2015","unstructured":"Klonowska K, Ratajska M, Czubak K, Kuzniacka A, Brozek I, Koczkowska M, Sniadecki M, Debniak J, Wydra D, Balut M, Stukan M, Zmienko A, Nowakowska B, Irminger-Finger I, Limon J, Kozlowski P (2015) Analysis of large mutations in BARD1 in patients with breast and\/or ovarian cancer: the Polish population as an example. Sci Rep 5:10424","journal-title":"Sci Rep"},{"issue":"9","key":"8215_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2004.020669","volume":"41","author":"SM Karppinen","year":"2004","unstructured":"Karppinen SM, Heikkinen K, Rapakko K, Winqvist R (2004) Mutation screening of the BARD1 gene: evidence for involvement of the Cys557Ser allele in hereditary susceptibility to breast cancer. J Med Genet 41(9):e114","journal-title":"J Med Genet"},{"issue":"2","key":"8215_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/sj.ejhg.5201542","volume":"14","author":"P Vahteristo","year":"2006","unstructured":"Vahteristo P, Syrj\u00e4koski K, Heikkinen T, Eerola H, Aittom\u00e4ki K, von Smitten K, Holli K, Blomqvist C, Kallioniemi OP, Nevanlinna H (2006) BARD1 variants Cys557Ser and Val507Met in breast cancer predisposition. Eur J Hum Genet EJHG 14(2):167\u2013172","journal-title":"Eur J Hum Genet EJHG"},{"issue":"6","key":"8215_CR28","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/humu.22785","volume":"36","author":"LB Hesson","year":"2015","unstructured":"Hesson LB, Packham D, Kwok CT, Nunez AC, Ng B, Schmidt C, Fields M, Wong JW, Sloane MA, Ward RL (2015) Lynch syndrome associated with two MLH1 promoter variants and allelic imbalance of MLH1 expression. Hum Mutat 36(6):622\u2013630","journal-title":"Hum Mutat"},{"issue":"5","key":"8215_CR29","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.3892\/or.2016.5060","volume":"36","author":"K Lagerstedt-Robinson","year":"2016","unstructured":"Lagerstedt-Robinson K, Rohlin A, Aravidis C, Melin B, Nordling M, StenmarkAskmalm M, Lindblom A, Nilbert M (2016) Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population. Oncol Rep 36(5):2823\u20132835","journal-title":"Oncol Rep"},{"issue":"16","key":"8215_CR30","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1016\/j.ejca.2006.04.024","volume":"42","author":"H Fredriksson","year":"2006","unstructured":"Fredriksson H, Ikonen T, Autio V, Matikainen MP, Helin HJ, Tammela TL, Koivisto PA, Schleutker J (2006) Identification of germline MLH1 alterations in familial prostate cancer. Eur J Cancer 42(16):2802\u20132806","journal-title":"Eur J Cancer"},{"issue":"5","key":"8215_CR31","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1074\/jbc.M111.311241","volume":"287","author":"K Somyajit","year":"2012","unstructured":"Somyajit K, Subramanya S, Nagaraju G (2012) Distinct roles of FANCO\/RAD51C protein in DNA damage signaling and repair: implications for Fanconi anemia and breast cancer susceptibility. J Biol Chem 287(5):3366\u20133380","journal-title":"J Biol Chem"},{"issue":"1","key":"8215_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/carcin\/bgu211","volume":"36","author":"K Somyajit","year":"2015","unstructured":"Somyajit K, Mishra A, Jameei A, Nagaraju G (2015) Enhanced non-homologous end joining contributes toward synthetic lethality of pathological RAD51C mutants with poly (ADPribose) polymerase. Carcinogenesis 36(1):13\u201324","journal-title":"Carcinogenesis"},{"issue":"26","key":"8215_CR33","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1200\/JCO.2015.61.2408","volume":"33","author":"H Song","year":"2015","unstructured":"Song H, Dicks E, Ramus SJ, Tyrer JP, Intermaggio MP, Hayward J, Edlund CK, Conti D, Harrington P, Fraser L, Philpott S, Anderson C, Rosenthal A, GentryMaharaj A, Bowtell DD, Alsop K, Cicek MS, Cunningham JM, Fridley BL, Alsop J, Pharoah PD (2015) Contribution of germline mutations in the RAD51B, RAD51C, and RAD51D genes to ovarian cancer in the population. J Clin Oncol 33(26):2901\u20132907","journal-title":"J Clin Oncol"},{"issue":"5","key":"8215_CR34","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/ng.2224","volume":"44","author":"C Loveday","year":"2012","unstructured":"Loveday C, Turnbull C, Ruark E, Xicola RM, Ramsay E, Hughes D, Warren-Perry M, Snape K, Collaboration BCS (UK), Eccles D, Evans DG, Gore M, Renwick A, Seal S, Antoniou AC, Rahman N (2012) Germline RAD51C mutations confer susceptibility to ovarian cancer. Nat Genet 44(5):475\u2013476","journal-title":"Nat Genet"},{"issue":"3","key":"8215_CR35","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/cam4.1004","volume":"6","author":"X Liu","year":"2017","unstructured":"Liu X, Li H, Shao B, Wu J, Kong W, Song G, Jiang H, Wang J, Wan F (2017) Identification of recurrent BRCA1 mutation and its clinical relevance in Chinese Triplenegative breast cancer cohort. Cancer Med 6(3):547\u2013554","journal-title":"Cancer Med"},{"issue":"1","key":"8215_CR36","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1186\/s12885-019-5756-4","volume":"19","author":"GN Tsaousis","year":"2019","unstructured":"Tsaousis GN, Papadopoulou E, Apessos A, Agiannitopoulos K, Pepe G, Kampouri S, Diamantopoulos N, Floros T, Iosifidou R, Katopodi O, Koumarianou A, Markopoulos Ch, Papazisis K, Venizelos V, Xanthakis I, Xepapadakis G, Banu E, Eniu E, Negru S, Stanculeanu D, Ungureanu A, Ozmen V, Tansan V, Tekinel M, Yalcin S, Nasioulas G (2019) Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations. BMC Cancer 19(1):535","journal-title":"BMC Cancer"},{"issue":"1","key":"8215_CR37","doi-asserted-by":"crossref","first-page":"52","DOI":"10.32471\/exp-oncology.2312-8852.vol-43-no-1.15587","volume":"43","author":"P Gervas","year":"2021","unstructured":"Gervas P, Molokov A, Ivanova A, Panferova Y, Kiselev A, Chernyshova A, Pisareva L, Choynzonov E, Cherdyntseva N (2021) New germline mutations in BRCA1, ATM, MUTYH, and RAD51D genes in Tuvans early-onset breast cancer patients. Exp Oncol 43(1):52\u201355","journal-title":"Exp Oncol"},{"issue":"4","key":"8215_CR38","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/cam4.1376","volume":"7","author":"J Hauke","year":"2018","unstructured":"Hauke J, Horvath J, Grob A, Gehrig A, Honisch E, Hackmann K, Schmidt G, Arnold N, Faust U, Sutter C, Hentschel J, Wang-Gohrke S, Smogavec M, Bernhard HF, Weber-Lassalle N, Weber-Lassalle S, Borde J, Ernst C (2018) Gene panel testing of 5589 BRCA1\/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer. Cancer Med 7(4):1349\u20131358","journal-title":"Cancer Med"},{"issue":"4","key":"8215_CR39","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ajhg.2009.08.018","volume":"85","author":"S Tavtigian","year":"2009","unstructured":"Tavtigian S, Oefner P, Babikyan D, Hartmann A, Healey S, Calvez-Kelm F, Lesueur F, Byrnes F, Chuang S, Forey S, Feuchtinger S (2009) Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer. Am J Hum Genet 85(4):427\u2013446","journal-title":"Am J Hum Genet"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-08215-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-022-08215-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-08215-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T03:48:56Z","timestamp":1728618536000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-022-08215-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,28]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["8215"],"URL":"https:\/\/doi.org\/10.1007\/s11033-022-08215-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2022,12,28]]},"assertion":[{"value":"4 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the Biomedical Ethics Committee at the Research Institute of Oncology of the Federal State Budgetary Scientific Institution \"Tomsk National Research Medical Center of the Russian Academy of Sciences (ethical standards of the institutional committee) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}